Amyloidosis

The FDA ( U.S. Food and Drug Administration ) has approved Darzalex Faspro ( Daratumumab and Hyaluronidase-fihj ), a...


HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated ( ATTR )...


Full positive results from the HELIOS-A phase 3 study of Vutrisiran, an investigational RNAi therapeutic in development for the treatment...


The role of induction therapy prior to autologous stem cell transplant ( ASCT ) in immunoglobulin light chain ( AL...


Transthyretin ( TTR ) amyloidosis is a progressive systemic disorder caused by misfolded TTR monomers that cumulatively deposit in the...


As preclinical Alzheimer's disease becomes a target for therapeutic intervention, the overlap between imaging abnormalities associated with typical ageing and...


Transthyretin amyloidosis is caused by the deposition of hepatocyte-derived transthyretin amyloid in peripheral nerves and the heart. A therapeutic approach...


A study led by researchers from the Amyloidosis Center at Boston University School of Medicine ( BUSM ) and Boston...


A study has shown that Etanercept ( Embrel ) reduces the frequency and severity of symptoms of TNF receptor-associated periodic...


The FDA ( Food and Drug Administration ) has approved a drug to help ease the suffering faced by those...


A study, directed by Mount Sinai School of Medicine, suggests that experimental dietary regimens might calm or even reverse symptoms...


Abnormal glucose metabolism, which occurs when the body has difficulty processing glucose into energy, is twice as common among patients...